We are live on ! Find out more
TOI icon

The Oncology Institute
TOI

29 hedge funds and large institutions have $159M invested in The Oncology Institute in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

38% more funds holding

Funds holding: 21 → 29 (+8)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0.48% more ownership

Funds ownership: 28.31% → 28.79% (+0.48%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

21% less capital invested

Capital invested by funds: $200M → $159M (-$41.2M)

Holders
29
Holders Change
+8
Holders Change %
+38.1%
% of All Funds
0.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
8
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.67M
2
Millennium Management
Millennium Management
New York
+$1.08M
3
ECM
ExodusPoint Capital Management
New York
+$511K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$467K
5
State Street
State Street
Massachusetts
+$210K

Top Sellers

1
AGM
Alpine Global Management
New York
-$2.32M
2
CH
CVI Holdings
Delaware
-$1.95M
3
EAM
Empery Asset Management
New York
-$872K
4
Goldman Sachs
Goldman Sachs
New York
-$716K
5
RG
Redmile Group
California
-$577K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$85.6M – – –
DM
2
Deerfield Management
New York
$32.1M – – –
RG
3
Redmile Group
California
$17.2M -$577K -85,568 -3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.98M +$2.67M +395,977 +90%
VCIM
5
Velan Capital Investment Management
Georgia
$4.28M – – –
PGM
6
Parian Global Management
New York
$3.17M -$151K -22,432 -5%
TM
7
Triatomic Management
California
$3.05M +$190K +28,100 +7%
SCM
8
Saba Capital Management
New York
$2.85M – – –
Millennium Management
9
Millennium Management
New York
$1.14M +$1.08M +159,823 New
ECM
10
ExodusPoint Capital Management
New York
$759K +$511K +75,805 +247%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$573K +$467K +69,255 +621%
EAM
12
Empery Asset Management
New York
$504K -$872K -129,267 -65%
Citadel Advisors
13
Citadel Advisors
Florida
$431K +$140K +20,826 +53%
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
$270K +$129K +19,162 +103%
State Street
15
State Street
Massachusetts
$222K +$210K +31,100 New
JMPWA
16
JP Morgan Private Wealth Advisors
California
$130K +$123K +18,300 New
Northern Trust
17
Northern Trust
Illinois
$129K +$122K +18,065 New
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$78K +$73.4K +10,873 New
Goldman Sachs
19
Goldman Sachs
New York
$72K -$716K -106,065 -91%
Bank of America
20
Bank of America
North Carolina
$69K +$65K +9,638 New
Morgan Stanley
21
Morgan Stanley
New York
$33K +$23.9K +3,543 +380%
PCM
22
Penserra Capital Management
California
$21K -$13.4K -1,988 -39%
OCM
23
Ovata Capital Management
Hong Kong
$8K +$7.42K +1,100 New
SOW
24
State of Wyoming
Wyoming
$7K +$6.52K +967 New
TRCT
25
Tower Research Capital (TRC)
New York
$6K +$4.15K +615 +308%
1
2

TOI Hedge Fund Activity: Q1 2022 in Review

29 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q1 2022, worth a combined $159M — down 21% from $200M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TOI positions and 2 closed out — a net gain of 8 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.67M. The largest seller was Alpine Global Management, cutting an estimated $2.32M.

  • 29 institutional investors held The Oncology Institute (TOI) as of Q1 2022, up from 21 in Q4 2021.
  • Funds reported $159M of The Oncology Institute stock for Q1 2022, down 21% quarter-over-quarter.
  • 10 funds opened new The Oncology Institute positions in Q1 2022 and 2 closed out, a net change of +8 holders.
  • The largest The Oncology Institute buyer in Q1 2022 was Vanguard Group, an estimated $2.67M added.
  • The largest The Oncology Institute seller in Q1 2022 was Alpine Global Management, an estimated $2.32M sold.

Based on aggregated 13F filings for Q1 2022.